Die Life-Sciences-Branche ist sehr heterogen und umfasst weltweit t盲tige Pharmaunternehmen ebenso wie kleine MedTech-Start-ups und innovative Biotech-Forschungslabore. Dass es dennoch gemeinsame Themen und Strategien gibt, zeigt der 乐鱼（Leyu）体育官网 2024 Life Sciences CEO Outlook. Hierf眉r wurden weltweit 120 CEOs der Life-Sciences-Branche befragt.
Die Ergebnisse zeigen: Die Wachstumsaussichten werden 眉berwiegend positiv gesehen. Dennoch ringen viele Unternehmen damit, Digitalisierung und die KI-Einf眉hrung zu beschleunigen. 脺berdies ist den CEOs bewusst, wie wichtig das Themenfeld ESG (Environmental, Social, Governance) f眉r das Vertrauen der 脰ffentlichkeit und das eigene Wachstum ist. Gleichzeitig zeigen sich viele in der Umfrage unsicher, wie sie ihre Netto-Null-Emissionsziele erreichen k枚nnen. Eine weitere dr盲ngende Unsicherheit ist der Fachkr盲ftemangel.
Meino M眉ller
Divisional Head of Performance & Strategy
乐鱼（Leyu）体育官网 AG Wirtschaftspr眉fungsgesellschaft
The most important findings at a glance:
- Almost 80 per cent of CEOs are positive about their company's growth prospects.
- For 60 per cent, generative AI has the highest investment priority.
- Less than half of those surveyed believe they will be able to achieve their company's net-zero emissions targets by 2030.
- The biggest challenge in the area of human resources: replacing ageing employees with new skilled workers.
Download now
乐鱼（Leyu）体育官网 2024 Life Sciences CEO Outlook
The results presented here are based on the responses of 120 executives from the life sciences sector, including 45 per cent from the pharmaceuticals sector and 19 per cent from the biotech sector. The most represented countries by company headquarters are the USA, Japan, India, China and Germany.
In addition, 乐鱼（Leyu）体育官网 publishes an annual cross-industry and cross-market CEO Outlook. In 2024, more than 1,300 CEOs were surveyed for this purpose. Their companies have an annual turnover of more than 500 million US dollars, and a third have a turnover of more than 10 billion US dollars.
CEOs in the industry continue to focus on controlling overall costs. At the same time, they are not losing sight of the necessary investments in AI. This strategic combination makes sense.
